Global Non-animal Type Hard Capsules Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Non-animal Type Hard Capsules Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 111

Published Date: 05 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Non-animal Type Hard Capsules market size was valued at USD 1034.5 million in 2022 and is forecast to a readjusted size of USD 1431.3 million by 2029 with a CAGR of 4.7% during review period.

The global Non-animal Type Hard Capsules market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 223%.

The Global Info Research report includes an overview of the development of the Non-animal Type Hard Capsules industry chain, the market status of Pharmaceutical (Type I, 00E), Nutraceutical (Type I, 00E), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-animal Type Hard Capsules.

Regionally, the report analyzes the Non-animal Type Hard Capsules markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-animal Type Hard Capsules market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Non-animal Type Hard Capsules market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-animal Type Hard Capsules industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Type I, 00E).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-animal Type Hard Capsules market.

Regional Analysis: The report involves examining the Non-animal Type Hard Capsules market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-animal Type Hard Capsules market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Non-animal Type Hard Capsules:
Company Analysis: Report covers individual Non-animal Type Hard Capsules manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-animal Type Hard Capsules This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical, Nutraceutical).

Technology Analysis: Report covers specific technologies relevant to Non-animal Type Hard Capsules. It assesses the current state, advancements, and potential future developments in Non-animal Type Hard Capsules areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-animal Type Hard Capsules market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Non-animal Type Hard Capsules market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Type I
00E
0E

Market segment by Application
Pharmaceutical
Nutraceutical
Cosmetics

Major players covered
Lonza
Catalent
ACG Associated Capsules
Qualicaps (Mitsubishi Chemical)
Bahrain Pharma
JC Biological Technology
CapsCanada
Medicaps
Aenova
Patheon (Banner Pharmacaps)
Roxlor
Sunil Healthcare
Arab-Caps
Jedco International Pharmaceutical
Pharco
ACPL
Hunan Er-Kang Pharmaceutical Co., Ltd
Procaps S.A

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-animal Type Hard Capsules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-animal Type Hard Capsules, with price, sales, revenue and global market share of Non-animal Type Hard Capsules from 2018 to 2023.
Chapter 3, the Non-animal Type Hard Capsules competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-animal Type Hard Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-animal Type Hard Capsules market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-animal Type Hard Capsules.
Chapter 14 and 15, to describe Non-animal Type Hard Capsules sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Non-animal Type Hard Capsules
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-animal Type Hard Capsules Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Type I
1.3.3 00E
1.3.4 0E
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-animal Type Hard Capsules Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical
1.4.3 Nutraceutical
1.4.4 Cosmetics
1.5 Global Non-animal Type Hard Capsules Market Size & Forecast
1.5.1 Global Non-animal Type Hard Capsules Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-animal Type Hard Capsules Sales Quantity (2018-2029)
1.5.3 Global Non-animal Type Hard Capsules Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Non-animal Type Hard Capsules Product and Services
2.1.4 Lonza Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments/Updates
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business
2.2.3 Catalent Non-animal Type Hard Capsules Product and Services
2.2.4 Catalent Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Catalent Recent Developments/Updates
2.3 ACG Associated Capsules
2.3.1 ACG Associated Capsules Details
2.3.2 ACG Associated Capsules Major Business
2.3.3 ACG Associated Capsules Non-animal Type Hard Capsules Product and Services
2.3.4 ACG Associated Capsules Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ACG Associated Capsules Recent Developments/Updates
2.4 Qualicaps (Mitsubishi Chemical)
2.4.1 Qualicaps (Mitsubishi Chemical) Details
2.4.2 Qualicaps (Mitsubishi Chemical) Major Business
2.4.3 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product and Services
2.4.4 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Qualicaps (Mitsubishi Chemical) Recent Developments/Updates
2.5 Bahrain Pharma
2.5.1 Bahrain Pharma Details
2.5.2 Bahrain Pharma Major Business
2.5.3 Bahrain Pharma Non-animal Type Hard Capsules Product and Services
2.5.4 Bahrain Pharma Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bahrain Pharma Recent Developments/Updates
2.6 JC Biological Technology
2.6.1 JC Biological Technology Details
2.6.2 JC Biological Technology Major Business
2.6.3 JC Biological Technology Non-animal Type Hard Capsules Product and Services
2.6.4 JC Biological Technology Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 JC Biological Technology Recent Developments/Updates
2.7 CapsCanada
2.7.1 CapsCanada Details
2.7.2 CapsCanada Major Business
2.7.3 CapsCanada Non-animal Type Hard Capsules Product and Services
2.7.4 CapsCanada Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CapsCanada Recent Developments/Updates
2.8 Medicaps
2.8.1 Medicaps Details
2.8.2 Medicaps Major Business
2.8.3 Medicaps Non-animal Type Hard Capsules Product and Services
2.8.4 Medicaps Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Medicaps Recent Developments/Updates
2.9 Aenova
2.9.1 Aenova Details
2.9.2 Aenova Major Business
2.9.3 Aenova Non-animal Type Hard Capsules Product and Services
2.9.4 Aenova Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Aenova Recent Developments/Updates
2.10 Patheon (Banner Pharmacaps)
2.10.1 Patheon (Banner Pharmacaps) Details
2.10.2 Patheon (Banner Pharmacaps) Major Business
2.10.3 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product and Services
2.10.4 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Patheon (Banner Pharmacaps) Recent Developments/Updates
2.11 Roxlor
2.11.1 Roxlor Details
2.11.2 Roxlor Major Business
2.11.3 Roxlor Non-animal Type Hard Capsules Product and Services
2.11.4 Roxlor Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Roxlor Recent Developments/Updates
2.12 Sunil Healthcare
2.12.1 Sunil Healthcare Details
2.12.2 Sunil Healthcare Major Business
2.12.3 Sunil Healthcare Non-animal Type Hard Capsules Product and Services
2.12.4 Sunil Healthcare Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sunil Healthcare Recent Developments/Updates
2.13 Arab-Caps
2.13.1 Arab-Caps Details
2.13.2 Arab-Caps Major Business
2.13.3 Arab-Caps Non-animal Type Hard Capsules Product and Services
2.13.4 Arab-Caps Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Arab-Caps Recent Developments/Updates
2.14 Jedco International Pharmaceutical
2.14.1 Jedco International Pharmaceutical Details
2.14.2 Jedco International Pharmaceutical Major Business
2.14.3 Jedco International Pharmaceutical Non-animal Type Hard Capsules Product and Services
2.14.4 Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Jedco International Pharmaceutical Recent Developments/Updates
2.15 Pharco
2.15.1 Pharco Details
2.15.2 Pharco Major Business
2.15.3 Pharco Non-animal Type Hard Capsules Product and Services
2.15.4 Pharco Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Pharco Recent Developments/Updates
2.16 ACPL
2.16.1 ACPL Details
2.16.2 ACPL Major Business
2.16.3 ACPL Non-animal Type Hard Capsules Product and Services
2.16.4 ACPL Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 ACPL Recent Developments/Updates
2.17 Hunan Er-Kang Pharmaceutical Co., Ltd
2.17.1 Hunan Er-Kang Pharmaceutical Co., Ltd Details
2.17.2 Hunan Er-Kang Pharmaceutical Co., Ltd Major Business
2.17.3 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product and Services
2.17.4 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments/Updates
2.18 Procaps S.A
2.18.1 Procaps S.A Details
2.18.2 Procaps S.A Major Business
2.18.3 Procaps S.A Non-animal Type Hard Capsules Product and Services
2.18.4 Procaps S.A Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Procaps S.A Recent Developments/Updates

3 Competitive Environment: Non-animal Type Hard Capsules by Manufacturer
3.1 Global Non-animal Type Hard Capsules Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-animal Type Hard Capsules Revenue by Manufacturer (2018-2023)
3.3 Global Non-animal Type Hard Capsules Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-animal Type Hard Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-animal Type Hard Capsules Manufacturer Market Share in 2022
3.4.2 Top 6 Non-animal Type Hard Capsules Manufacturer Market Share in 2022
3.5 Non-animal Type Hard Capsules Market: Overall Company Footprint Analysis
3.5.1 Non-animal Type Hard Capsules Market: Region Footprint
3.5.2 Non-animal Type Hard Capsules Market: Company Product Type Footprint
3.5.3 Non-animal Type Hard Capsules Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Non-animal Type Hard Capsules Market Size by Region
4.1.1 Global Non-animal Type Hard Capsules Sales Quantity by Region (2018-2029)
4.1.2 Global Non-animal Type Hard Capsules Consumption Value by Region (2018-2029)
4.1.3 Global Non-animal Type Hard Capsules Average Price by Region (2018-2029)
4.2 North America Non-animal Type Hard Capsules Consumption Value (2018-2029)
4.3 Europe Non-animal Type Hard Capsules Consumption Value (2018-2029)
4.4 Asia-Pacific Non-animal Type Hard Capsules Consumption Value (2018-2029)
4.5 South America Non-animal Type Hard Capsules Consumption Value (2018-2029)
4.6 Middle East and Africa Non-animal Type Hard Capsules Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
5.2 Global Non-animal Type Hard Capsules Consumption Value by Type (2018-2029)
5.3 Global Non-animal Type Hard Capsules Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
6.2 Global Non-animal Type Hard Capsules Consumption Value by Application (2018-2029)
6.3 Global Non-animal Type Hard Capsules Average Price by Application (2018-2029)

7 North America
7.1 North America Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
7.2 North America Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
7.3 North America Non-animal Type Hard Capsules Market Size by Country
7.3.1 North America Non-animal Type Hard Capsules Sales Quantity by Country (2018-2029)
7.3.2 North America Non-animal Type Hard Capsules Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
8.2 Europe Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
8.3 Europe Non-animal Type Hard Capsules Market Size by Country
8.3.1 Europe Non-animal Type Hard Capsules Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-animal Type Hard Capsules Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-animal Type Hard Capsules Market Size by Region
9.3.1 Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-animal Type Hard Capsules Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
10.2 South America Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
10.3 South America Non-animal Type Hard Capsules Market Size by Country
10.3.1 South America Non-animal Type Hard Capsules Sales Quantity by Country (2018-2029)
10.3.2 South America Non-animal Type Hard Capsules Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-animal Type Hard Capsules Market Size by Country
11.3.1 Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-animal Type Hard Capsules Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Non-animal Type Hard Capsules Market Drivers
12.2 Non-animal Type Hard Capsules Market Restraints
12.3 Non-animal Type Hard Capsules Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Non-animal Type Hard Capsules and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-animal Type Hard Capsules
13.3 Non-animal Type Hard Capsules Production Process
13.4 Non-animal Type Hard Capsules Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-animal Type Hard Capsules Typical Distributors
14.3 Non-animal Type Hard Capsules Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Non-animal Type Hard Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-animal Type Hard Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Lonza Basic Information, Manufacturing Base and Competitors
Table 4. Lonza Major Business
Table 5. Lonza Non-animal Type Hard Capsules Product and Services
Table 6. Lonza Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Lonza Recent Developments/Updates
Table 8. Catalent Basic Information, Manufacturing Base and Competitors
Table 9. Catalent Major Business
Table 10. Catalent Non-animal Type Hard Capsules Product and Services
Table 11. Catalent Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Catalent Recent Developments/Updates
Table 13. ACG Associated Capsules Basic Information, Manufacturing Base and Competitors
Table 14. ACG Associated Capsules Major Business
Table 15. ACG Associated Capsules Non-animal Type Hard Capsules Product and Services
Table 16. ACG Associated Capsules Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ACG Associated Capsules Recent Developments/Updates
Table 18. Qualicaps (Mitsubishi Chemical) Basic Information, Manufacturing Base and Competitors
Table 19. Qualicaps (Mitsubishi Chemical) Major Business
Table 20. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product and Services
Table 21. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Qualicaps (Mitsubishi Chemical) Recent Developments/Updates
Table 23. Bahrain Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Bahrain Pharma Major Business
Table 25. Bahrain Pharma Non-animal Type Hard Capsules Product and Services
Table 26. Bahrain Pharma Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Bahrain Pharma Recent Developments/Updates
Table 28. JC Biological Technology Basic Information, Manufacturing Base and Competitors
Table 29. JC Biological Technology Major Business
Table 30. JC Biological Technology Non-animal Type Hard Capsules Product and Services
Table 31. JC Biological Technology Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. JC Biological Technology Recent Developments/Updates
Table 33. CapsCanada Basic Information, Manufacturing Base and Competitors
Table 34. CapsCanada Major Business
Table 35. CapsCanada Non-animal Type Hard Capsules Product and Services
Table 36. CapsCanada Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CapsCanada Recent Developments/Updates
Table 38. Medicaps Basic Information, Manufacturing Base and Competitors
Table 39. Medicaps Major Business
Table 40. Medicaps Non-animal Type Hard Capsules Product and Services
Table 41. Medicaps Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Medicaps Recent Developments/Updates
Table 43. Aenova Basic Information, Manufacturing Base and Competitors
Table 44. Aenova Major Business
Table 45. Aenova Non-animal Type Hard Capsules Product and Services
Table 46. Aenova Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Aenova Recent Developments/Updates
Table 48. Patheon (Banner Pharmacaps) Basic Information, Manufacturing Base and Competitors
Table 49. Patheon (Banner Pharmacaps) Major Business
Table 50. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product and Services
Table 51. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Patheon (Banner Pharmacaps) Recent Developments/Updates
Table 53. Roxlor Basic Information, Manufacturing Base and Competitors
Table 54. Roxlor Major Business
Table 55. Roxlor Non-animal Type Hard Capsules Product and Services
Table 56. Roxlor Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Roxlor Recent Developments/Updates
Table 58. Sunil Healthcare Basic Information, Manufacturing Base and Competitors
Table 59. Sunil Healthcare Major Business
Table 60. Sunil Healthcare Non-animal Type Hard Capsules Product and Services
Table 61. Sunil Healthcare Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sunil Healthcare Recent Developments/Updates
Table 63. Arab-Caps Basic Information, Manufacturing Base and Competitors
Table 64. Arab-Caps Major Business
Table 65. Arab-Caps Non-animal Type Hard Capsules Product and Services
Table 66. Arab-Caps Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Arab-Caps Recent Developments/Updates
Table 68. Jedco International Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Jedco International Pharmaceutical Major Business
Table 70. Jedco International Pharmaceutical Non-animal Type Hard Capsules Product and Services
Table 71. Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Jedco International Pharmaceutical Recent Developments/Updates
Table 73. Pharco Basic Information, Manufacturing Base and Competitors
Table 74. Pharco Major Business
Table 75. Pharco Non-animal Type Hard Capsules Product and Services
Table 76. Pharco Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pharco Recent Developments/Updates
Table 78. ACPL Basic Information, Manufacturing Base and Competitors
Table 79. ACPL Major Business
Table 80. ACPL Non-animal Type Hard Capsules Product and Services
Table 81. ACPL Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. ACPL Recent Developments/Updates
Table 83. Hunan Er-Kang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 84. Hunan Er-Kang Pharmaceutical Co., Ltd Major Business
Table 85. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product and Services
Table 86. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 88. Procaps S.A Basic Information, Manufacturing Base and Competitors
Table 89. Procaps S.A Major Business
Table 90. Procaps S.A Non-animal Type Hard Capsules Product and Services
Table 91. Procaps S.A Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Procaps S.A Recent Developments/Updates
Table 93. Global Non-animal Type Hard Capsules Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 94. Global Non-animal Type Hard Capsules Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Non-animal Type Hard Capsules Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 96. Market Position of Manufacturers in Non-animal Type Hard Capsules, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Non-animal Type Hard Capsules Production Site of Key Manufacturer
Table 98. Non-animal Type Hard Capsules Market: Company Product Type Footprint
Table 99. Non-animal Type Hard Capsules Market: Company Product Application Footprint
Table 100. Non-animal Type Hard Capsules New Market Entrants and Barriers to Market Entry
Table 101. Non-animal Type Hard Capsules Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Non-animal Type Hard Capsules Sales Quantity by Region (2018-2023) & (K Units)
Table 103. Global Non-animal Type Hard Capsules Sales Quantity by Region (2024-2029) & (K Units)
Table 104. Global Non-animal Type Hard Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Non-animal Type Hard Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Non-animal Type Hard Capsules Average Price by Region (2018-2023) & (USD/Unit)
Table 107. Global Non-animal Type Hard Capsules Average Price by Region (2024-2029) & (USD/Unit)
Table 108. Global Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Global Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Global Non-animal Type Hard Capsules Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Non-animal Type Hard Capsules Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Non-animal Type Hard Capsules Average Price by Type (2018-2023) & (USD/Unit)
Table 113. Global Non-animal Type Hard Capsules Average Price by Type (2024-2029) & (USD/Unit)
Table 114. Global Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Global Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Global Non-animal Type Hard Capsules Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Non-animal Type Hard Capsules Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Non-animal Type Hard Capsules Average Price by Application (2018-2023) & (USD/Unit)
Table 119. Global Non-animal Type Hard Capsules Average Price by Application (2024-2029) & (USD/Unit)
Table 120. North America Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 121. North America Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 122. North America Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 123. North America Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 124. North America Non-animal Type Hard Capsules Sales Quantity by Country (2018-2023) & (K Units)
Table 125. North America Non-animal Type Hard Capsules Sales Quantity by Country (2024-2029) & (K Units)
Table 126. North America Non-animal Type Hard Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Non-animal Type Hard Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 129. Europe Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 130. Europe Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 131. Europe Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 132. Europe Non-animal Type Hard Capsules Sales Quantity by Country (2018-2023) & (K Units)
Table 133. Europe Non-animal Type Hard Capsules Sales Quantity by Country (2024-2029) & (K Units)
Table 134. Europe Non-animal Type Hard Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Non-animal Type Hard Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 137. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 138. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 139. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 140. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Region (2018-2023) & (K Units)
Table 141. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Region (2024-2029) & (K Units)
Table 142. Asia-Pacific Non-animal Type Hard Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Non-animal Type Hard Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 145. South America Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 146. South America Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 147. South America Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 148. South America Non-animal Type Hard Capsules Sales Quantity by Country (2018-2023) & (K Units)
Table 149. South America Non-animal Type Hard Capsules Sales Quantity by Country (2024-2029) & (K Units)
Table 150. South America Non-animal Type Hard Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Non-animal Type Hard Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 153. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 154. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 155. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 156. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Region (2018-2023) & (K Units)
Table 157. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Region (2024-2029) & (K Units)
Table 158. Middle East & Africa Non-animal Type Hard Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Non-animal Type Hard Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Non-animal Type Hard Capsules Raw Material
Table 161. Key Manufacturers of Non-animal Type Hard Capsules Raw Materials
Table 162. Non-animal Type Hard Capsules Typical Distributors
Table 163. Non-animal Type Hard Capsules Typical Customers
List of Figures
Figure 1. Non-animal Type Hard Capsules Picture
Figure 2. Global Non-animal Type Hard Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-animal Type Hard Capsules Consumption Value Market Share by Type in 2022
Figure 4. Type I Examples
Figure 5. 00E Examples
Figure 6. 0E Examples
Figure 7. Global Non-animal Type Hard Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Non-animal Type Hard Capsules Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical Examples
Figure 10. Nutraceutical Examples
Figure 11. Cosmetics Examples
Figure 12. Global Non-animal Type Hard Capsules Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Non-animal Type Hard Capsules Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Non-animal Type Hard Capsules Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Non-animal Type Hard Capsules Average Price (2018-2029) & (USD/Unit)
Figure 16. Global Non-animal Type Hard Capsules Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Non-animal Type Hard Capsules Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Non-animal Type Hard Capsules by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Non-animal Type Hard Capsules Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Non-animal Type Hard Capsules Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Non-animal Type Hard Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Non-animal Type Hard Capsules Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Non-animal Type Hard Capsules Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Non-animal Type Hard Capsules Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Non-animal Type Hard Capsules Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Non-animal Type Hard Capsules Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Non-animal Type Hard Capsules Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Non-animal Type Hard Capsules Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Non-animal Type Hard Capsules Average Price by Type (2018-2029) & (USD/Unit)
Figure 31. Global Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Non-animal Type Hard Capsules Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Non-animal Type Hard Capsules Average Price by Application (2018-2029) & (USD/Unit)
Figure 34. North America Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Non-animal Type Hard Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Non-animal Type Hard Capsules Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Non-animal Type Hard Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Non-animal Type Hard Capsules Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Non-animal Type Hard Capsules Consumption Value Market Share by Region (2018-2029)
Figure 54. China Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Non-animal Type Hard Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Non-animal Type Hard Capsules Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Non-animal Type Hard Capsules Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Non-animal Type Hard Capsules Market Drivers
Figure 75. Non-animal Type Hard Capsules Market Restraints
Figure 76. Non-animal Type Hard Capsules Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Non-animal Type Hard Capsules in 2022
Figure 79. Manufacturing Process Analysis of Non-animal Type Hard Capsules
Figure 80. Non-animal Type Hard Capsules Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Lonza
Catalent
ACG Associated Capsules
Qualicaps (Mitsubishi Chemical)
Bahrain Pharma
JC Biological Technology
CapsCanada
Medicaps
Aenova
Patheon (Banner Pharmacaps)
Roxlor
Sunil Healthcare
Arab-Caps
Jedco International Pharmaceutical
Pharco
ACPL
Hunan Er-Kang Pharmaceutical Co., Ltd
Procaps S.A
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Non-animal Type Hard Capsules Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Non-animal Type Hard Capsules Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 111

Published Date: 05 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Non-animal Type Hard Capsules market size was valued at USD 1034.5 million in 2022 and is forecast to a readjusted size of USD 1431.3 million by 2029 with a CAGR of 4.7% during review period.

The global Non-animal Type Hard Capsules market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 223%.

The Global Info Research report includes an overview of the development of the Non-animal Type Hard Capsules industry chain, the market status of Pharmaceutical (Type I, 00E), Nutraceutical (Type I, 00E), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-animal Type Hard Capsules.

Regionally, the report analyzes the Non-animal Type Hard Capsules markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-animal Type Hard Capsules market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Non-animal Type Hard Capsules market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-animal Type Hard Capsules industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Type I, 00E).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-animal Type Hard Capsules market.

Regional Analysis: The report involves examining the Non-animal Type Hard Capsules market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-animal Type Hard Capsules market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Non-animal Type Hard Capsules:
Company Analysis: Report covers individual Non-animal Type Hard Capsules manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-animal Type Hard Capsules This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical, Nutraceutical).

Technology Analysis: Report covers specific technologies relevant to Non-animal Type Hard Capsules. It assesses the current state, advancements, and potential future developments in Non-animal Type Hard Capsules areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-animal Type Hard Capsules market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Non-animal Type Hard Capsules market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Type I
00E
0E

Market segment by Application
Pharmaceutical
Nutraceutical
Cosmetics

Major players covered
Lonza
Catalent
ACG Associated Capsules
Qualicaps (Mitsubishi Chemical)
Bahrain Pharma
JC Biological Technology
CapsCanada
Medicaps
Aenova
Patheon (Banner Pharmacaps)
Roxlor
Sunil Healthcare
Arab-Caps
Jedco International Pharmaceutical
Pharco
ACPL
Hunan Er-Kang Pharmaceutical Co., Ltd
Procaps S.A

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-animal Type Hard Capsules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-animal Type Hard Capsules, with price, sales, revenue and global market share of Non-animal Type Hard Capsules from 2018 to 2023.
Chapter 3, the Non-animal Type Hard Capsules competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-animal Type Hard Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-animal Type Hard Capsules market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-animal Type Hard Capsules.
Chapter 14 and 15, to describe Non-animal Type Hard Capsules sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Non-animal Type Hard Capsules
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-animal Type Hard Capsules Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Type I
1.3.3 00E
1.3.4 0E
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-animal Type Hard Capsules Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical
1.4.3 Nutraceutical
1.4.4 Cosmetics
1.5 Global Non-animal Type Hard Capsules Market Size & Forecast
1.5.1 Global Non-animal Type Hard Capsules Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-animal Type Hard Capsules Sales Quantity (2018-2029)
1.5.3 Global Non-animal Type Hard Capsules Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Non-animal Type Hard Capsules Product and Services
2.1.4 Lonza Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments/Updates
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business
2.2.3 Catalent Non-animal Type Hard Capsules Product and Services
2.2.4 Catalent Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Catalent Recent Developments/Updates
2.3 ACG Associated Capsules
2.3.1 ACG Associated Capsules Details
2.3.2 ACG Associated Capsules Major Business
2.3.3 ACG Associated Capsules Non-animal Type Hard Capsules Product and Services
2.3.4 ACG Associated Capsules Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ACG Associated Capsules Recent Developments/Updates
2.4 Qualicaps (Mitsubishi Chemical)
2.4.1 Qualicaps (Mitsubishi Chemical) Details
2.4.2 Qualicaps (Mitsubishi Chemical) Major Business
2.4.3 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product and Services
2.4.4 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Qualicaps (Mitsubishi Chemical) Recent Developments/Updates
2.5 Bahrain Pharma
2.5.1 Bahrain Pharma Details
2.5.2 Bahrain Pharma Major Business
2.5.3 Bahrain Pharma Non-animal Type Hard Capsules Product and Services
2.5.4 Bahrain Pharma Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bahrain Pharma Recent Developments/Updates
2.6 JC Biological Technology
2.6.1 JC Biological Technology Details
2.6.2 JC Biological Technology Major Business
2.6.3 JC Biological Technology Non-animal Type Hard Capsules Product and Services
2.6.4 JC Biological Technology Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 JC Biological Technology Recent Developments/Updates
2.7 CapsCanada
2.7.1 CapsCanada Details
2.7.2 CapsCanada Major Business
2.7.3 CapsCanada Non-animal Type Hard Capsules Product and Services
2.7.4 CapsCanada Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CapsCanada Recent Developments/Updates
2.8 Medicaps
2.8.1 Medicaps Details
2.8.2 Medicaps Major Business
2.8.3 Medicaps Non-animal Type Hard Capsules Product and Services
2.8.4 Medicaps Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Medicaps Recent Developments/Updates
2.9 Aenova
2.9.1 Aenova Details
2.9.2 Aenova Major Business
2.9.3 Aenova Non-animal Type Hard Capsules Product and Services
2.9.4 Aenova Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Aenova Recent Developments/Updates
2.10 Patheon (Banner Pharmacaps)
2.10.1 Patheon (Banner Pharmacaps) Details
2.10.2 Patheon (Banner Pharmacaps) Major Business
2.10.3 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product and Services
2.10.4 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Patheon (Banner Pharmacaps) Recent Developments/Updates
2.11 Roxlor
2.11.1 Roxlor Details
2.11.2 Roxlor Major Business
2.11.3 Roxlor Non-animal Type Hard Capsules Product and Services
2.11.4 Roxlor Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Roxlor Recent Developments/Updates
2.12 Sunil Healthcare
2.12.1 Sunil Healthcare Details
2.12.2 Sunil Healthcare Major Business
2.12.3 Sunil Healthcare Non-animal Type Hard Capsules Product and Services
2.12.4 Sunil Healthcare Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sunil Healthcare Recent Developments/Updates
2.13 Arab-Caps
2.13.1 Arab-Caps Details
2.13.2 Arab-Caps Major Business
2.13.3 Arab-Caps Non-animal Type Hard Capsules Product and Services
2.13.4 Arab-Caps Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Arab-Caps Recent Developments/Updates
2.14 Jedco International Pharmaceutical
2.14.1 Jedco International Pharmaceutical Details
2.14.2 Jedco International Pharmaceutical Major Business
2.14.3 Jedco International Pharmaceutical Non-animal Type Hard Capsules Product and Services
2.14.4 Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Jedco International Pharmaceutical Recent Developments/Updates
2.15 Pharco
2.15.1 Pharco Details
2.15.2 Pharco Major Business
2.15.3 Pharco Non-animal Type Hard Capsules Product and Services
2.15.4 Pharco Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Pharco Recent Developments/Updates
2.16 ACPL
2.16.1 ACPL Details
2.16.2 ACPL Major Business
2.16.3 ACPL Non-animal Type Hard Capsules Product and Services
2.16.4 ACPL Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 ACPL Recent Developments/Updates
2.17 Hunan Er-Kang Pharmaceutical Co., Ltd
2.17.1 Hunan Er-Kang Pharmaceutical Co., Ltd Details
2.17.2 Hunan Er-Kang Pharmaceutical Co., Ltd Major Business
2.17.3 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product and Services
2.17.4 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments/Updates
2.18 Procaps S.A
2.18.1 Procaps S.A Details
2.18.2 Procaps S.A Major Business
2.18.3 Procaps S.A Non-animal Type Hard Capsules Product and Services
2.18.4 Procaps S.A Non-animal Type Hard Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Procaps S.A Recent Developments/Updates

3 Competitive Environment: Non-animal Type Hard Capsules by Manufacturer
3.1 Global Non-animal Type Hard Capsules Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-animal Type Hard Capsules Revenue by Manufacturer (2018-2023)
3.3 Global Non-animal Type Hard Capsules Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-animal Type Hard Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-animal Type Hard Capsules Manufacturer Market Share in 2022
3.4.2 Top 6 Non-animal Type Hard Capsules Manufacturer Market Share in 2022
3.5 Non-animal Type Hard Capsules Market: Overall Company Footprint Analysis
3.5.1 Non-animal Type Hard Capsules Market: Region Footprint
3.5.2 Non-animal Type Hard Capsules Market: Company Product Type Footprint
3.5.3 Non-animal Type Hard Capsules Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Non-animal Type Hard Capsules Market Size by Region
4.1.1 Global Non-animal Type Hard Capsules Sales Quantity by Region (2018-2029)
4.1.2 Global Non-animal Type Hard Capsules Consumption Value by Region (2018-2029)
4.1.3 Global Non-animal Type Hard Capsules Average Price by Region (2018-2029)
4.2 North America Non-animal Type Hard Capsules Consumption Value (2018-2029)
4.3 Europe Non-animal Type Hard Capsules Consumption Value (2018-2029)
4.4 Asia-Pacific Non-animal Type Hard Capsules Consumption Value (2018-2029)
4.5 South America Non-animal Type Hard Capsules Consumption Value (2018-2029)
4.6 Middle East and Africa Non-animal Type Hard Capsules Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
5.2 Global Non-animal Type Hard Capsules Consumption Value by Type (2018-2029)
5.3 Global Non-animal Type Hard Capsules Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
6.2 Global Non-animal Type Hard Capsules Consumption Value by Application (2018-2029)
6.3 Global Non-animal Type Hard Capsules Average Price by Application (2018-2029)

7 North America
7.1 North America Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
7.2 North America Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
7.3 North America Non-animal Type Hard Capsules Market Size by Country
7.3.1 North America Non-animal Type Hard Capsules Sales Quantity by Country (2018-2029)
7.3.2 North America Non-animal Type Hard Capsules Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
8.2 Europe Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
8.3 Europe Non-animal Type Hard Capsules Market Size by Country
8.3.1 Europe Non-animal Type Hard Capsules Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-animal Type Hard Capsules Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-animal Type Hard Capsules Market Size by Region
9.3.1 Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-animal Type Hard Capsules Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
10.2 South America Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
10.3 South America Non-animal Type Hard Capsules Market Size by Country
10.3.1 South America Non-animal Type Hard Capsules Sales Quantity by Country (2018-2029)
10.3.2 South America Non-animal Type Hard Capsules Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-animal Type Hard Capsules Market Size by Country
11.3.1 Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-animal Type Hard Capsules Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Non-animal Type Hard Capsules Market Drivers
12.2 Non-animal Type Hard Capsules Market Restraints
12.3 Non-animal Type Hard Capsules Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Non-animal Type Hard Capsules and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-animal Type Hard Capsules
13.3 Non-animal Type Hard Capsules Production Process
13.4 Non-animal Type Hard Capsules Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-animal Type Hard Capsules Typical Distributors
14.3 Non-animal Type Hard Capsules Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Non-animal Type Hard Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-animal Type Hard Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Lonza Basic Information, Manufacturing Base and Competitors
Table 4. Lonza Major Business
Table 5. Lonza Non-animal Type Hard Capsules Product and Services
Table 6. Lonza Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Lonza Recent Developments/Updates
Table 8. Catalent Basic Information, Manufacturing Base and Competitors
Table 9. Catalent Major Business
Table 10. Catalent Non-animal Type Hard Capsules Product and Services
Table 11. Catalent Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Catalent Recent Developments/Updates
Table 13. ACG Associated Capsules Basic Information, Manufacturing Base and Competitors
Table 14. ACG Associated Capsules Major Business
Table 15. ACG Associated Capsules Non-animal Type Hard Capsules Product and Services
Table 16. ACG Associated Capsules Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ACG Associated Capsules Recent Developments/Updates
Table 18. Qualicaps (Mitsubishi Chemical) Basic Information, Manufacturing Base and Competitors
Table 19. Qualicaps (Mitsubishi Chemical) Major Business
Table 20. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product and Services
Table 21. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Qualicaps (Mitsubishi Chemical) Recent Developments/Updates
Table 23. Bahrain Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Bahrain Pharma Major Business
Table 25. Bahrain Pharma Non-animal Type Hard Capsules Product and Services
Table 26. Bahrain Pharma Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Bahrain Pharma Recent Developments/Updates
Table 28. JC Biological Technology Basic Information, Manufacturing Base and Competitors
Table 29. JC Biological Technology Major Business
Table 30. JC Biological Technology Non-animal Type Hard Capsules Product and Services
Table 31. JC Biological Technology Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. JC Biological Technology Recent Developments/Updates
Table 33. CapsCanada Basic Information, Manufacturing Base and Competitors
Table 34. CapsCanada Major Business
Table 35. CapsCanada Non-animal Type Hard Capsules Product and Services
Table 36. CapsCanada Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CapsCanada Recent Developments/Updates
Table 38. Medicaps Basic Information, Manufacturing Base and Competitors
Table 39. Medicaps Major Business
Table 40. Medicaps Non-animal Type Hard Capsules Product and Services
Table 41. Medicaps Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Medicaps Recent Developments/Updates
Table 43. Aenova Basic Information, Manufacturing Base and Competitors
Table 44. Aenova Major Business
Table 45. Aenova Non-animal Type Hard Capsules Product and Services
Table 46. Aenova Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Aenova Recent Developments/Updates
Table 48. Patheon (Banner Pharmacaps) Basic Information, Manufacturing Base and Competitors
Table 49. Patheon (Banner Pharmacaps) Major Business
Table 50. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product and Services
Table 51. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Patheon (Banner Pharmacaps) Recent Developments/Updates
Table 53. Roxlor Basic Information, Manufacturing Base and Competitors
Table 54. Roxlor Major Business
Table 55. Roxlor Non-animal Type Hard Capsules Product and Services
Table 56. Roxlor Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Roxlor Recent Developments/Updates
Table 58. Sunil Healthcare Basic Information, Manufacturing Base and Competitors
Table 59. Sunil Healthcare Major Business
Table 60. Sunil Healthcare Non-animal Type Hard Capsules Product and Services
Table 61. Sunil Healthcare Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sunil Healthcare Recent Developments/Updates
Table 63. Arab-Caps Basic Information, Manufacturing Base and Competitors
Table 64. Arab-Caps Major Business
Table 65. Arab-Caps Non-animal Type Hard Capsules Product and Services
Table 66. Arab-Caps Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Arab-Caps Recent Developments/Updates
Table 68. Jedco International Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Jedco International Pharmaceutical Major Business
Table 70. Jedco International Pharmaceutical Non-animal Type Hard Capsules Product and Services
Table 71. Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Jedco International Pharmaceutical Recent Developments/Updates
Table 73. Pharco Basic Information, Manufacturing Base and Competitors
Table 74. Pharco Major Business
Table 75. Pharco Non-animal Type Hard Capsules Product and Services
Table 76. Pharco Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pharco Recent Developments/Updates
Table 78. ACPL Basic Information, Manufacturing Base and Competitors
Table 79. ACPL Major Business
Table 80. ACPL Non-animal Type Hard Capsules Product and Services
Table 81. ACPL Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. ACPL Recent Developments/Updates
Table 83. Hunan Er-Kang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 84. Hunan Er-Kang Pharmaceutical Co., Ltd Major Business
Table 85. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product and Services
Table 86. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 88. Procaps S.A Basic Information, Manufacturing Base and Competitors
Table 89. Procaps S.A Major Business
Table 90. Procaps S.A Non-animal Type Hard Capsules Product and Services
Table 91. Procaps S.A Non-animal Type Hard Capsules Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Procaps S.A Recent Developments/Updates
Table 93. Global Non-animal Type Hard Capsules Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 94. Global Non-animal Type Hard Capsules Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Non-animal Type Hard Capsules Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 96. Market Position of Manufacturers in Non-animal Type Hard Capsules, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Non-animal Type Hard Capsules Production Site of Key Manufacturer
Table 98. Non-animal Type Hard Capsules Market: Company Product Type Footprint
Table 99. Non-animal Type Hard Capsules Market: Company Product Application Footprint
Table 100. Non-animal Type Hard Capsules New Market Entrants and Barriers to Market Entry
Table 101. Non-animal Type Hard Capsules Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Non-animal Type Hard Capsules Sales Quantity by Region (2018-2023) & (K Units)
Table 103. Global Non-animal Type Hard Capsules Sales Quantity by Region (2024-2029) & (K Units)
Table 104. Global Non-animal Type Hard Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Non-animal Type Hard Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Non-animal Type Hard Capsules Average Price by Region (2018-2023) & (USD/Unit)
Table 107. Global Non-animal Type Hard Capsules Average Price by Region (2024-2029) & (USD/Unit)
Table 108. Global Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Global Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Global Non-animal Type Hard Capsules Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Non-animal Type Hard Capsules Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Non-animal Type Hard Capsules Average Price by Type (2018-2023) & (USD/Unit)
Table 113. Global Non-animal Type Hard Capsules Average Price by Type (2024-2029) & (USD/Unit)
Table 114. Global Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Global Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Global Non-animal Type Hard Capsules Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Non-animal Type Hard Capsules Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Non-animal Type Hard Capsules Average Price by Application (2018-2023) & (USD/Unit)
Table 119. Global Non-animal Type Hard Capsules Average Price by Application (2024-2029) & (USD/Unit)
Table 120. North America Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 121. North America Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 122. North America Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 123. North America Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 124. North America Non-animal Type Hard Capsules Sales Quantity by Country (2018-2023) & (K Units)
Table 125. North America Non-animal Type Hard Capsules Sales Quantity by Country (2024-2029) & (K Units)
Table 126. North America Non-animal Type Hard Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Non-animal Type Hard Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 129. Europe Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 130. Europe Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 131. Europe Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 132. Europe Non-animal Type Hard Capsules Sales Quantity by Country (2018-2023) & (K Units)
Table 133. Europe Non-animal Type Hard Capsules Sales Quantity by Country (2024-2029) & (K Units)
Table 134. Europe Non-animal Type Hard Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Non-animal Type Hard Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 137. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 138. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 139. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 140. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Region (2018-2023) & (K Units)
Table 141. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity by Region (2024-2029) & (K Units)
Table 142. Asia-Pacific Non-animal Type Hard Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Non-animal Type Hard Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 145. South America Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 146. South America Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 147. South America Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 148. South America Non-animal Type Hard Capsules Sales Quantity by Country (2018-2023) & (K Units)
Table 149. South America Non-animal Type Hard Capsules Sales Quantity by Country (2024-2029) & (K Units)
Table 150. South America Non-animal Type Hard Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Non-animal Type Hard Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 153. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 154. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 155. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 156. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Region (2018-2023) & (K Units)
Table 157. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity by Region (2024-2029) & (K Units)
Table 158. Middle East & Africa Non-animal Type Hard Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Non-animal Type Hard Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Non-animal Type Hard Capsules Raw Material
Table 161. Key Manufacturers of Non-animal Type Hard Capsules Raw Materials
Table 162. Non-animal Type Hard Capsules Typical Distributors
Table 163. Non-animal Type Hard Capsules Typical Customers
List of Figures
Figure 1. Non-animal Type Hard Capsules Picture
Figure 2. Global Non-animal Type Hard Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-animal Type Hard Capsules Consumption Value Market Share by Type in 2022
Figure 4. Type I Examples
Figure 5. 00E Examples
Figure 6. 0E Examples
Figure 7. Global Non-animal Type Hard Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Non-animal Type Hard Capsules Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical Examples
Figure 10. Nutraceutical Examples
Figure 11. Cosmetics Examples
Figure 12. Global Non-animal Type Hard Capsules Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Non-animal Type Hard Capsules Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Non-animal Type Hard Capsules Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Non-animal Type Hard Capsules Average Price (2018-2029) & (USD/Unit)
Figure 16. Global Non-animal Type Hard Capsules Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Non-animal Type Hard Capsules Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Non-animal Type Hard Capsules by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Non-animal Type Hard Capsules Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Non-animal Type Hard Capsules Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Non-animal Type Hard Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Non-animal Type Hard Capsules Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Non-animal Type Hard Capsules Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Non-animal Type Hard Capsules Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Non-animal Type Hard Capsules Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Non-animal Type Hard Capsules Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Non-animal Type Hard Capsules Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Non-animal Type Hard Capsules Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Non-animal Type Hard Capsules Average Price by Type (2018-2029) & (USD/Unit)
Figure 31. Global Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Non-animal Type Hard Capsules Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Non-animal Type Hard Capsules Average Price by Application (2018-2029) & (USD/Unit)
Figure 34. North America Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Non-animal Type Hard Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Non-animal Type Hard Capsules Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Non-animal Type Hard Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Non-animal Type Hard Capsules Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Non-animal Type Hard Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Non-animal Type Hard Capsules Consumption Value Market Share by Region (2018-2029)
Figure 54. China Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Non-animal Type Hard Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Non-animal Type Hard Capsules Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Non-animal Type Hard Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Non-animal Type Hard Capsules Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Non-animal Type Hard Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Non-animal Type Hard Capsules Market Drivers
Figure 75. Non-animal Type Hard Capsules Market Restraints
Figure 76. Non-animal Type Hard Capsules Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Non-animal Type Hard Capsules in 2022
Figure 79. Manufacturing Process Analysis of Non-animal Type Hard Capsules
Figure 80. Non-animal Type Hard Capsules Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Lonza
Catalent
ACG Associated Capsules
Qualicaps (Mitsubishi Chemical)
Bahrain Pharma
JC Biological Technology
CapsCanada
Medicaps
Aenova
Patheon (Banner Pharmacaps)
Roxlor
Sunil Healthcare
Arab-Caps
Jedco International Pharmaceutical
Pharco
ACPL
Hunan Er-Kang Pharmaceutical Co., Ltd
Procaps S.A
jiaGou

Add To Cart

gouMai

Buy Now